Streptococcus pyogenes (Group A Strep)

Last updated: August 11, 2025

Streptococcus pyogenes (Group A Strep)

E Respi

E Respi

Upper respiratory tract infection
Upper respiratory tract infections: Clinical sciences
Rhinovirus
Anatomy of the nose and paranasal sinuses
Sinusitis
Streptococcus pneumoniae
Nasal, oral and pharyngeal diseases: Pathology review
Anatomy of the external and middle ear
Anatomy clinical correlates: Ear
Otitis media
Otitis media and externa (pediatrics): Clinical sciences
Haemophilus influenzae
Moraxella catarrhalis
Streptococcus pyogenes (Group A Strep)
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
KIF1A-associated neurological disorder: Year of the Zebra
Poststreptococcal glomerulonephritis
Coxsackievirus
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Epstein-Barr virus (Infectious mononucleosis)
Adenovirus
Retropharyngeal and peritonsillar abscesses
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Croup
Human parainfluenza viruses
Croup and epiglottitis: Clinical sciences
Respiratory syncytial virus
Bronchiolitis: Clinical sciences
Immunizations (adult): Clinical sciences
Influenza virus
Neuraminidase inhibitors
Influenza: Clinical sciences
The flu vaccine: Information for patients and families
COVID-19: Clinical sciences
Obstructive lung diseases: Pathology review
Asthma
Asthma: Clinical sciences
Tobacco use disorder
Tobacco use: Clinical sciences
Approach to a cough (acute): Clinical sciences
Approach to a cough (subacute and chronic): Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to chest pain: Clinical sciences
Approach to a fever: Clinical sciences
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Tuberculosis (pulmonary): Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Antituberculosis medications
Cystic fibrosis: Pathology review
Cystic fibrosis
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Reading a chest X-ray
Chest X-ray interpretation: Clinical sciences
Pneumocystis jirovecii (Pneumocystis pneumonia)
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome
Acute respiratory distress syndrome: Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Deep vein thrombosis and pulmonary embolism: Pathology review
Pulmonary embolism
Pulmonary embolism: Clinical sciences

Transcript

Watch video only

Streptococcus pyogenes, sometimes called Strep pyogenes, can be broken down into “strepto” which means chain, “coccus”, which refers to round shape, “pyo” which means pus, and “genes” which refers to forming.

So, Strep pyogenes are round bacteria that grow in chains, responsible for a number of infections that often present with pus. Strep pyogenes are also called Group A StrepGAS - in Lancefield classification developed by American microbiologist Rebecca Lancefield. 

Ok now, Strep pyogenes has a thick peptidoglycan cell wall, which takes in purple dye when Gram-stained - so this is a gram-positive bacteria.

It’s non-motile and doesn’t form spores, and it’s also a facultative anaerobe, meaning it can survive in both aerobic and anaerobic environments.

Finally, Strep pyogenes is catalase negative, meaning it doesn’t make an enzyme called catalase. 

However, unlike other common cocci like Enterococci, Strep pyogenes is pyrrolidonyl arylamidase positive, because it makes an enzyme called L-pyrrolidonyl arylamidase.

To test for this, a small sample is taken from a suspected bacterial colony, and then inoculated to a disk pad that’s embedded with pyrrolidonyl beta naphthylamide - another joy of a word.

With Strep pyogenes, pyrrolidonyl arylamidase hydrolyzes pyrrolidonyl beta—naphthylamide to produce beta-naphthylamide.

Try saying that 3 times fast! Finally, another reagent called N-methylamino-cinnamaldehyde is added to the disk, and it reacts with beta—naphthylamide, resulting in a bright red color that confirms Strep pyogenes is pyrrolidonyl arylamidase positive.

When cultivated on a medium called blood agar, Strep pyogenes colonies cause  beta-hemolysis, also called complete hemolysis. That’s because Strep pyogenes makes toxins known as streptolysins, which hydrolyze the hemoglobin in red blood cells to transparent yellow color byproducts. 

But some other Streptococcus species, like Strep agalactiae, are also beta-hemolytic. So a bacitracin test is done to distinguish Strep pyogenes.

That’s when a disk of bacitracin is added to the blood agar. Strep pyogenes is bacitracin sensitive, so the colonies die off, whereas with Strep agalactiae, the colonies remain intact.  

Now, Strep pyogenes has a number of virulence factors, that are like assault weaponry that help it attack and destroy the host cells, and evade the immune system.

So first, Strep pyogenes is encapsulated, meaning it’s covered by a polysaccharide layer called a capsule.

And on the capsule, there are adherence proteins such as lipoteichoic acid, Streptococcus fibronectin binding protein - or Sfbl for short, and M protein, which help Strep pyogenes attach to the host cells, like those in the skin or the pharyngeal mucosa. 

Then, Strep pyogenes uses toxins like hyaluronidase, which destroys hyaluronic acid, a cement substance that keeps cells of the connective tissues and blood vessels tightly linked.

Destruction of hyaluronic acid results in local inflammation, and enables the bacteria to spread to the bloodstream.

In the bloodstream, Strep pyogenes uses streptolysin O and S, which are toxins that cause hemolysis, or red blood cell destruction.

It also uses erythrogenic toxins, that are also called Streptococcal Pyrogenic Exotoxins, or Spe for short, which come in 3 flavors: SpeA, SpeB, and SpeC.

This leads to increased hemolysis in the dermal and submucosal blood capillaries. What is more, SpeA and SpeC are superantigens, meaning they don’t need to be eaten up and processed by an antigen-presenting cell such as a macrophage to generate an immune response from T-cells.

Instead, they interact immediately with the class II MHC molecule on the surface of the macrophage, forming a superantigen-MHC complex, which then interacts with the T-cell receptor and stimulates up to 30% of the entire T- cell population.

This is 300 times powerful the conventional antigens, and it stimulates the release of a whole bunch of inflammatory cytokines.

Specifically, this is called a cytokine storm, and it can result in toxic shock syndrome or TSS, which happens when a such  cytokine storm triggers widespread systemic vasodilation, making blood pressure drop, which leads to poor perfusion of vital organs.

From the bloodstream, strep pyogenes bacteria can spread to other organs, like the lungs, causing pneumonia or lung abscesses, or the heart, where they form clumps called vegetations on the heart valves, causing infective endocarditis.

Alternatively, if they spread to central nervous system, they can cause brain abscesses, or meningitis.

Surprisingly, despite all that powerful arsenal, Strep pyogenes can actually peacefully colonize the skin, the mucosa of the pharynx or throat, the vagina, and the rectum.

It doesn’t do any harm so long as the immune system keeps them in check, restricting their growth and preventing them from spreading somewhere else in the body.

Problems arise in individuals with weaker immune systems, like infants and the elderly. Other immune-weakening conditions include HIV infection, diabetes, or a malignancy.

In these cases, Strep pyogenes usually gets in the bloodstream through a breach on the skin, a mucosal laceration, or following surgery. 

Most often, Strep pyogenes causes strep pharyngitis also called strep throat, which is the inflammation of the pharyngeal mucosa and tonsils.

Strep pharyngitis may also be associated with scarlet fever, which is when intracapillary hemolysis results in a bright-red skin rash.

When Strep pyogenes infects the epidermis, it causes impetigo, which are superficial skin lesions that look like honey clusters.

Key Takeaways

Streptococcus pyogenes, often called group A streptococcus (GAS), is a gram-positive, beta-hemolytic, and bacitracin-sensitive bacteria. Group A streptococcus normally colonize the pharynx, vagina, or the skin, where they're part of the normal flora, but in some cases, they may take advantage of a weakened immune system and causes infections like strep pharyngitis, scarlet fever, impetigo, necrotizing fasciitis. Infections due to certain strains of this bacteria can involve certain bacterial toxins, leading to scarlet fever or toxic shock syndrome. Group A streptococcus is also associated with post-infectious sequelae, like acute rheumatic fever and post-streptococcal glomerulonephritis. Treatment involves antibiotics like penicillin G, cephalosporins such as ceftriaxone, and macrolides such as azithromycin.

Sources

  1. "Antibiotics to eradicate Streptococcus pyogenes pharyngeal carriage in asymptomatic children and adults: A systematic review. 88(3):106104." J Infect (2024)
  2. "Streptococcal superantigens and the return of scarlet fever. 2021;17(12):e1010097" PLoS Pathog. (Published 2021 Dec 30. )
  3. "Global genomic epidemiology of Streptococcus pyogenes. 86:104609. " Infect Genet Evol. (2020)
  4. "Robbins & Kumar Basic Pathology. 11th edition. ISBN: 978-0-323-79018-5 " Elsevier (2022)
  5. "Harrison’s Principles of Internal Medicine. 21st edition. ISBN: 978-1-264-26850-4 " McGraw Hill / Medical (2022)
  6. "The Bacteriophages of Streptococcus pyogenes. 7(3):10.1128/microbiolspec.GPP3-0059-2018. " Microbiol Spectr. (2019)